Table 1 The relative binding free energy and energy components (kcal/mol) for the five HLA-DR/Top1 complexes predicted by the MM-PB(GB)SA and QM/MM-GBSA methods.
From: Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis
Energy Component | HLA-DRB1*08:02a | HLA-DRB1*11:01a | HLA-DRB1*11:04a | HLA-DRB5*01:02b | HLA-DRB1*01:01c |
---|---|---|---|---|---|
Gas term | |||||
∆EvdW | −143.5 ± 2.3 | −134.2 ± 1.6 | −139.2 ± 3.0 | −137.4 ± 1.1 | −132.4 ± 2.0 |
∆Eele | −584.7 ± 25.4 | −599.1 ± 9.0 | −576.4 ± 25.9 | −769.5 ± 14.3 | −498.3 ± 22.9 |
∆EMM | −728.2 ± 25.5 | −733.4 ± 8.1 | −715.6 ± 27.3 | −906.9 ± 15.2 | −630.7 ± 23.6 |
∆E QM | −22.5 ± 2.5 | −33.9 ± 1.0 | −36.7 ± 0.8 | −47.4 ± 4.0 | −24.6 ± 1.7 |
−T∆S | 65.8 ± 1.7 | 66.2 ± 1.2 | 67.9 ± 1.2 | 69.3 ± 1.8 | 73.6 ± 2.3 |
Solvation term | |||||
∆Gsol(PBSA) | 609.7 ± 25.0 | 620.1 ± 7.1 | 600.0 ± 24.6 | 786.3 ± 13.1 | 516.2 ± 22.6 |
∆Gsol(GBSA) | 608.8 ± 23.8 | 613.3 ± 7.3 | 596.6 ± 25.4 | 780.0 ± 13.1 | 517.0 ± 21.5 |
∆Gsol(QM-GBSA) | 629.2 ± 23.7 | 652.3 ± 8.1 | 623.8 ± 24.7 | 819.2 ± 12.2 | 575.8 ± 23.0 |
Binding free energy | |||||
∆Gbind(MM/PBSA) | −52.7 ± 3.3 | −47.0 ± 1.2 | −47.8 ± 3.5 | −51.2 ± 2.7 | −40.9 ± 2.1 |
∆Gbind(MM/GBSA) | −53.6 ± 1.4 | −53.4 ± 0.6 | −51.1 ± 1.7 | −57.6 ± 2.7 | −40.1 ± 1.2 |
∆Gbind(QM/MM-GBSA) | −33.4 ± 1.4 | −36.5 ± 0.6 | −33.2 ± 1.8 | −37.5 ± 2.3 | −21.2 ± 1.7 |
Relative binding free energy | |||||
∆∆Gbind(MM/PBSA) | −11.8 | −6.1 | −6.9 | −10.3 | 0 |
∆∆Gbind(MM/GBSA) | −13.5 | −13.3 | −11.0 | −17.5 | 0 |
∆∆Gbind(QM/MM-GBSA) | −12.2 | −15.3 | −12.0 | −16.3 | 0 |